Interferon-induced anti-HBE seroconversion correlates with a Th1 cytokine shift following emergence of core promoter mutations in chronic hepatitis B.
Zampino
Rosa
R
Durante Mangoni
Emanuele
E
Marrone
Aldo
A
Utili
Riccardo
R
Ruggiero
Giuseppe
G
Adinolfi
Luigi Elio
LE
D000998:Antiviral Agents / Q000627:therapeutic use; D016207:Cytokines / Q000097:blood*; D005500:Follow-Up Studies; D006513:Hepatitis B e Antigens / Q000097:blood*; D006515:Hepatitis B virus / Q000235:genetics*; D019694:Hepatitis B, Chronic / Q000097:blood* / Q000188:drug therapy; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use; D009154:Mutation / Q000235:genetics*; D011401:Promoter Regions, Genetic / Q000235:genetics*; D016896:Treatment Outcome
D000998:Antiviral Agents; D016207:Cytokines; D006513:Hepatitis B e Antigens; D016898:Interferon-alpha